NANETTE PAREDES: Open Payments
NPI 1437175163 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,051 in 115 payments from 22 companies in 2025. Trend: 2023 $1,518 · 2024 $1,931 · 2025 $2,051
Food & beverage: $2,051
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $273 |
| PFIZER INC. | 13 | $228 |
| ABBVIE INC. | 12 | $194 |
| Lundbeck LLC | 12 | $173 |
| Novartis Pharmaceuticals Corporation | 9 | $168 |
| SK Life Science, Inc. | 10 | $166 |
| Biogen, Inc. | 11 | $165 |
| Teva Pharmaceuticals USA, Inc. | 10 | $141 |
| ARGENX US, INC. | 4 | $87 |
| Amgen Inc. | 4 | $82 |
Products named: NURTEC ODT, KESIMPTA, REXULTI, VUMERITY, AUSTEDO XR, Briviact, UBRELVY, Nayzilam.
Industry payments across TX — which companies pay providers there.
